Mirivadelgat
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Foresee Pharmaceuticals Co., Ltd.
Overview
Mirivadelgat is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Mirivadelgat clinical trials
Explore related
Medical disclaimer. This page summarizes research about Mirivadelgat for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.